A. Hossain

发表

A Multicenter Phase II Study of Single-Agent Enzastaurin in Previously Treated Waldenström Macroglobulinemia

Tuan S. Nguyen, P. Moreau, I. Ghobrial, 2012, Clinical Cancer Research.

Effect of Teriparatide {rhPTH(1‐34)} on BMD When Given to Postmenopausal Women Receiving Hormone Replacement Therapy

S. Schwartz, G. Gaich, L. Ste-Marie, 2005, Journal of bone and mineral research : the official journal of the American Society for Bone and Mineral Research.

An exploratory subgroup analysis of race and gender in squamous cancer of the head and neck: inferior outcomes for African American males in the LORHAN database.

C. Obasaju, D. Hayes, A. Hossain, 2014, Oral oncology.

Potent Cell-Cycle Inhibition and Upregulation of Immune Response with Abemaciclib and Anastrozole in neoMONARCH, Phase II Neoadjuvant Study in HR+/HER2− Breast Cancer

Chiun-Sheng Huang, D. Slamon, M. Press, 2019, Clinical Cancer Research.

Phase II study of pemetrexed in combination with cisplatin and cetuximab in recurrent or metastatic squamous cell carcinoma of the head and neck.

T. Gauler, A. Dietz, O. Hamid, 2013, European journal of cancer.

An East Asian subgroup analysis of PROCLAIM, a phase III trial of pemetrexed and cisplatin or etoposide and cisplatin plus thoracic radiation therapy followed by consolidation chemotherapy in locally advanced nonsquamous non–small cell lung cancer

M. Ahn, Yi-long Wu, M. Orlando, 2016, Asia-Pacific journal of clinical oncology.

Healthcare resource utilization and associated cost analysis of the PROCLAIM study in patients with stage III non-small-cell lung cancer

R. Govindan, K. Syrigos, Yi-long Wu, 2019, Current medical research and opinion.

Sustained Nonvertebral Fragility Fracture Risk Reduction After Discontinuation of Teriparatide Treatment

G. Dalsky, B. Mitlak, R. Lindsay, 2005, Journal of bone and mineral research : the official journal of the American Society for Bone and Mineral Research.

Quality of life scores as prognostic factors of overall survival in advanced head and neck cancer: analysis of a phase III randomized trial of pemetrexed plus cisplatin versus cisplatin monotherapy.

W. Shen, E. Cohen, A. Hossain, 2012, Oral oncology.

Radiation Therapy Quality Assurance (RTQA) of Concurrent Chemoradiation Therapy for Locally Advanced Non-Small Cell Lung Cancer in the PROCLAIM Phase 3 Trial.

S. Senan, F. Wenz, A. Brade, 2018, International journal of radiation oncology, biology, physics.

A phase Ib study of abemaciclib in combination with pembrolizumab for patients with hormone receptor positive (HR+), human epidermal growth factor receptor 2 negative (HER2-) locally advanced or metastatic breast cancer (MBC) (NCT02779751): Interim results.

H. Rugo, P. Kabos, S. Tolaney, 2020 .

Abemaciclib in combination with pembrolizumab for HR+, HER2− metastatic breast cancer: Phase 1b study

H. Rugo, H. Wildiers, L. Paz-Ares, 2022, npj Breast Cancer.

Abemaciclib in Combination With Pembrolizumab for Stage IV KRAS-Mutant or Squamous NSCLC: A Phase 1b Study

P. Jänne, J. Mazières, J. Vansteenkiste, 2021, JTO clinical and research reports.

Abemaciclib in Combination with Single-Agent Options in Patients with Stage IV Non–Small Cell Lung Cancer: A Phase Ib Study

Edward S. Kim, K. Kelly, L. Paz-Ares, 2018, Clinical Cancer Research.

A randomized phase 3 study of abemaciclib versus erlotinib in previously treated patients with stage IV NSCLC with KRAS mutation: JUNIPER.

N. Girard, Keunchil Park, L. Paz-Ares, 2018 .

A Randomized Phase III Study of Abemaciclib Versus Erlotinib in Patients with Stage IV Non-small Cell Lung Cancer With a Detectable KRAS Mutation Who Failed Prior Platinum-Based Therapy: JUNIPER

N. Girard, Keunchil Park, L. Paz-Ares, 2020, Frontiers in Oncology.

Cetuximab and Radiotherapy in Laryngeal Preservation for Cancers of the Larynx and Hypopharynx: A Secondary Analysis of a Randomized Clinical Trial.

P. Harari, S. Spencer, J. Giralt, 2016, JAMA otolaryngology-- head & neck surgery.

PROCLAIM: Randomized Phase III Trial of Pemetrexed-Cisplatin or Etoposide-Cisplatin Plus Thoracic Radiation Therapy Followed by Consolidation Chemotherapy in Locally Advanced Nonsquamous Non-Small-Cell Lung Cancer.

R. Govindan, H. Choy, T. Mok, 2016, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

The Impact of Staging by Positron‐Emission Tomography on Overall Survival and Progression‐Free Survival in Patients With Locally Advanced NSCLC

R. Govindan, E. Vokes, S. Senan, 2018, Journal of thoracic oncology : official publication of the International Association for the Study of Lung Cancer.

Phase II Study of Concurrent Pemetrexed, Cisplatin, and Radiation Therapy for Stage IIIA/B Unresectable Non-Small Cell Lung Cancer.

A. Bezjak, F. Shepherd, A. Hope, 2016, Clinical lung cancer.

A multicenter phase II study of single-agent enzastaurin in previously treated multiple myeloma

Tuan S. Nguyen, P. Moreau, V. Leblond, 2014, Leukemia & lymphoma.

Pemetrexed in combination with cisplatin versus cisplatin monotherapy in patients with recurrent or metastatic head and neck cancer

D. Shin, C. Reuter, R. Hitt, 2012, Cancer.

Phase I and Pharmacokinetic Study of Pemetrexed plus Cisplatin in Chemonaive Patients with Locally Advanced or Metastatic Malignant Pleural Mesothelioma or Non–Small Cell Lung Cancer

Michael Thomas, J. Latz, L. Musib, 2009, Clinical Cancer Research.

Phase I and Pharmacokinetic Study of Pemetrexed plus Cisplatin in Chemonaive Patients with LocallyAdvanced or Metastatic Malignant Pleural Mesothelioma or Non ^ Small Cell Lung Cancer

J. Latz, L. Musib, A. Hossain, 2008 .

Teriparatide effects on vertebral fractures and bone mineral density in men with osteoporosis: treatment and discontinuation of therapy

J. Kaufman, G. Dalsky, B. Mitlak, 2005, Osteoporosis International.